Stocks · Health care · Biological Products, (No Diagnostic Substances)

Solid Biosciences Inc.

SLDB Clue Score20
United States Fiscal year ends December CIK 0001707502 Results filed 6 Mar 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Ilan Ganot
2 May 2024
Director
Sold after exercise indirect
462
$10.33
$4.77K
Kevin Tan
9 Jan 2024
CFO & Treasurer
Sold after exercise
3,935
$8.20
$32.27K
Ilan Ganot
3 Jan 2024
Director
Sold after exercise indirect
1,142
$5.30
$6.05K
Ilan Ganot
2 May 2023
Director
Sold after exercise indirect
487
$4.85
$2.36K
Ilan Ganot
27 Jan 2023
Director
Sold after exercise
1,382
$7.49
$10.35K
Ilan Ganot
27 Jan 2023
Director
Sold after exercise indirect
141
$7.49
$1.06K
Carl Ashley Morris
27 Jan 2023
Chief Scientific Officer
Sold after exercise
441
$7.49
$3.30K

What was left out

Form 4 filings counted 337
Amendments (4/A) skipped 6
Filings about a different issuer 0
Unreadable filings 0
Joint filings 29
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 7
Sales at will 59
Transactions with no price 0
Shares from compensation/vesting 31,237,837
Sales filed before the plan box existed 43
History held since 30 Jan 2018